Financials
- Market Capitalization 231.56 M
- Employee 51
- Founded 2006
- CEO N/A
- Website www.protaratx.com
- Headquarter New York, United States
- FIGI BBG001ZLYSH5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.83
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3516 | FULC Fulcrum Therapeutics, Inc. - Common Stock | 3.56 USD | -0.84% | -4.56% | +2.01% | -54.71% | 237.21 M USD | ||
| 3534 | AVXL Anavex Life Sciences Corp. - Common Stock | 2.50 USD | +2.88% | -7.75% | -3.85% | -77.68% | 231.68 M USD | ||
| 3553 | DTIL Precision BioSciences, Inc. - Common Stock | 8.81 USD | +2.68% | -3.40% | +39.84% | +97.98% | 227.32 M USD | ||
| 3562 | CGEN Compugen Ltd. - Ordinary Shares | 2.36 USD | +2.61% | -4.45% | +16.26% | +56.29% | 223.15 M USD |